The purpose of this research was to develop mouth dissolve tablets of cinnarizine by effervescent, superdisintegrant addition and sublimation methods. All the three formulations were evaluated for disintegration time, hardness and friability, among these superdisintegrant addition method showed lowest disintegration time; hence it was selected for further studies. Further nine batches (B1-B9) were prepared by using crospovidone, croscarmellose sodium and L-HPC in different concentrations such as 5, 7.5 and 10%. All the formulations were evaluated for weight variation, hardness, friability, drug content, in vitro disintegration time, wetting time, in vitro dissolution. Formulation with 10% L-HPC showed the less disintegration time (25.3 s) and less wetting time (29.1 s) . In vitro dissolution studies showed total drug release at the end of 6 min.
Mouth dissolving tablet disintegrate or dissolve in saliva and are swallowed without the need for water. They offer an advantage over swallowing tablets and capsules. Difficulty to swallow is particularly experienced by pediatric and geriatric patients. Technique that are frequently employed in the preparation of mouth dissolving tablets include, freeze drying, sublimation, spray drying, moulding, mass extrusion and direct compression [1] .
Cinnarizine is a H1-receptor antagonist that is widely used in the treatment of motion sickness, vomiting and vertigo. It is water insoluble and tasteless [2] . Hence it was select as a model drug for the preparation of mouth dissolving tablets. In the present work effervescent, superdisintegrant addition and sublimation technique were tried for formulation of tablets. Superdisintegrant addition method was found as best and further study carried out using three superdisintegrants in different ratios.
Cinnarizine was received as a gift sample from Erica Pharma, Mumbai. Crospovidone (Collidon), croscarmellose sodium (Ac-di-Sol), L-HPC and MCC (Avicel PH 102) were gift sample from Signet Chemical Corporation, Mumbai. Mannitol, camphor, sodium bicarbonate, citric acid, aspartame, and magnesium stearate were procured from Nice Chemicals (P) Ltd, Cochin. All other reagents were of analytical grade.
Mouth dissolving tablets of cinnarizine were prepared by effervescent, superdisintegrant addition and sublimation technique by direct compression method. Cinnarizine 200 mg tablets each containing 25 mg of drug were prepared. In all formulation mannitol was common diluents. The formulation of cinnarizine mouth dissolving tablet prepared by different methods is given in Table 1. For tablets prepared by effervescent method, specified quantity of cinnarizine, mannitol, Avicel 102, aspartame, talc and magnesium stearate were weighed accurately and passed through 60 # screen. Sodium bicarbonate and citric acid were accurately weighed and preheated at a temperature of 70 o . All All the quantities are in mg. All the tablets contain 1% Aspartame, 1% Mgstearate and 2% Talc the materials were transferred to mortar and triturated till it mixed uniformly. The resulting powder mixture was compressed into tablets using single punch tablet machine using 9 mm fl at surface punches [3] .
For tablets prepared by sublimation technique, specifi ed quantity of cinnarizine, camphor, mannitol, talc and magnesium stearate were weighed accurately and passed through 60 # screen prior to mixing. All the materials were transferred to mortar and triturated till it mixed uniformly. The resulting powder mixture was compressed into tablets using single punch tablet machine. The tablets were dried at 60 o in oven till constant weigh obtained [4] . For tablets prepared by superdisintegrant addition method, specifi ed quantities of cinnarizine, mannitol, Avicel 102, aspartame, crospovidone, talc and magnesium stearate were weighed accurately and passed through 60 # screen. All the materials were transferred to a mortar and triturated till it was uniform. The resulting powder blend was evaluated for angle of repose, bulk density, tap density and compressibility index [5] and compressed into tablets using single punch tablet machine [6] . Tablets thus prepared using this method was given in Table 2 .
The prepared tablets were evaluated as per IP. Twenty tablets from each batch were weighed accurately and powdered powder equivalent to 100 mg cinnarizine was shaken with 100 ml of 0.1N HCl in 100 ml volumetric fl ask and from this 1 ml was pipette out and than dilute up to 100 ml. Resulting solution was fi ltered and assayed at 253.5 nm using double beem UV/Vis spectrometer and content of cinnarizine was calculated.
Friability (F) was determined using a Roche model friabilator and the hardness was determined using a Monsanto hardness tester (Sheetal Scientifi c Industries, Mumbai, India). The in vitro disintegration time was determined using disintegration test apparatus. The time in seconds taken for complete disintegration of the tablet with no palatable mass remaining in the apparatus was measured in seconds. Disintegration test was carried out in distilled water as medium [7] . All evaluation parameters are given in Table 3 .
A piece of tissue paper folded double was placed in a Petri dish (internal diameter is 6.5 cm) containing 6 ml of water. The tablet was placed on the paper, and the time for complete wetting of the tablet was measured in seconds. The method was slightly modified by maintaining water at 37  . Wetting time corresponds to the time taken for the tablet to disintegrate when kept motionless on the tongue [8] .
The drug-release study was carried out using a USP XXIV type-2 apparatus (Electrolab, TDT-06T, India) at 37±0.5° and at 50 rpm using 900 ml of 0.1N HCl as a dissolution medium (n=3). A sample (5 ml) of the solution was withdrawn from the dissolution apparatus at 2, 4, 6, 8 and 10 min and withdrawn volume was replaced with fresh dissolution media. The withdrawn samples filtered through a 0.45-micrometer membrane fi lter, diluted suitably, and analyzed spectrophotometrically.
Various methods were tried for formulation of mouth dissolving tablets. The disintegration time of tablets prepared by various methods are shown in Table 3 . It shows that super disintegration addition Ingredient  B1  B2  B3  B4  B5  B6  B7  B8  B9  Cinnarizine  25  25  25  25  25  25  25  25  25  Crospovidone  10  15  20  -----Croscarmellose sodium  ---10  15  20  ---L-HPC  ------1 0  1 5  2 0  Avicel 102  60  60  60  60  60  60  60  60  60  Mannitol up to…  200  200  200  200  200  200  200  200  200 All the quantities are in mg. All the tablets contain 1% Aspartame, 1% Mg-stearate and 2% Talc o indicating only fair flow property of the powder blend. Compressibility index was found to be in the range 11.86% to 19.18%. All formulations showed good fl ow properties except formulation containing L-HPC 7.5% and 10% (Table 4 ).
All the formulated (B1 to B9) tablets passed weight variation test as the % weight variation was within the IP limits of 7.5% of the weight. The average thickness of the all formulation was found to be 2.58 mm and with in the limit of standard Pharmacopoeia. The hardness of the tablet was found to be 2.5 to 3.0 kg/cm 2 . The maximum friability of the formulation was found to be 0.8%. The minimum friability of the formulation was found to be 0.65%. The % friability was less than 1% in all the formulations ensuring that the tablets were mechanically stable. The results of drug content were within the limit specifi ed by the IP.
In vitro disintegration time was found to be in the range 25.3 to 59.4 second. From all formulations, B9 (10% L-HPC) has minimum time of disintegration. Formulations containing croscarmellose sodium has taken more time for disintegration because of its gelling properties. Wetting time was found to be in the range 29.1 to 89 s. From all formulations, B9 (10% L-HPC) has minimum wetting time (Table 5 ). All the 9 formulations were subjected to in vitro dissolution studies by using 0.1N HCl. Dissolution data shows that formulation B9 shows improved dissolution as compared to other formulations and more than 90% drug release was found at the end of 4 min (fi g. 1).
In the present work, mouth dissolving tablets were prepared by effervescent, superdisintegrant addition and sublimation technique by direct compression method, from all these techniques, superdisintegrant addition technique was selected based on least disintegration time.
The mouth dissolving tablets of cinnarizine were prepared by superdisintegrants addition method using crospovidone, croscarmellose sodium and L-HPC in different concentration like 5%, 7.5% and 10%. Mefenamic acid, N-(2,3-xylyl)-2-aminobenzoic acid, is an analgesic used for the treatment of arthritic pain. Some of the spectrophotometric estimation methods include conversion to its colored iron complex [1] . The derivatization of aromatic ring by using coupling reaction with diazotized 4-amino-3,5-dinitrobenzoic acid has been performed prior to photometric estimation of mefenamic acid [2] . Spectrophotometric methods have been developed for the simultaneous estimation of mefenamic acid and paracetamol [3, 4] , mefenamic acid and ethamsylate [5, 6] and mefenamic acid and drotaverine hydrochloride [7] in combination drugs. Mefenamic acid has a strong absorption band at 353 nm with high molar absorptivity but it has poor solubility in most organic solvents. We have observed that 1,4-dioxane is a good solvent for mefenamic acid but with low solubility of inactive ingredients in the tablet. Further, high boiling point (b.p. 100º) of dioxane provides accuracy for assay.
The solvent, 1,4-dioxane GR used for the experiment,
